Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:272-277

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez-Alfonso, M. S.
Right arrow Articles by Paul, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Alfonso, M. S.
Right arrow Articles by Paul, M.

(Hypertension. 1997;30:272-277.)
© 1997 American Heart Association, Inc.


Articles

Early Induction of Angiotensin I–Converting Enzyme in Rat Carotid Artery After Balloon Injury

Maria S. Fernandez-Alfonso; Piero A. Martorana; Ivo Licka; Paul van Even; Dieter Trobisch; Bernward A. Schölkens; ; Martin Paul

From the Departamento de Farmacologia, Facultad de Farmacia, Universidad Complutense, Madrid, Spain (M.S.F.-A.); Hoechst Marion Roussel, Pharma Forschung HMR TD, Cardiovascular Agents, Frankfurt am Main, Germany (P.A.M., P. van E., D.T., B.A.S.); and the Department of Clinical Pharmacology and Toxicology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany (I.L., M.P.).

Correspondence to Prof Martin Paul, Department of Clinical Pharmacology and Toxicology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail paul{at}ukbf.fu-berlin.de

Abstract Several studies have demonstrated the effectiveness of angiotensin I–converting enzyme (ACE) inhibitors in preventing the neointima formation found after denudation of the rat carotid artery by balloon injury. The aim of the present study was to determine the role of ACE in this model and to compare the treatment with the ACE inhibitor ramiprilat with that with the angiotensin II antagonist HR 720. The endothelial layer of the left carotid artery was removed using an inflated balloon catheter. Injured and control vessels were both submitted to histomorphological analysis and DNA content quantification at 2, 4, 6, 8, 12, and 14 days after injury. Evaluation of neointima thickening demonstrated a slow but steady increase of neointima that was significant after day 6 and reached 30% of the lumen in 2 weeks. This was paralleled by an increase in DNA content, which was significant 4 days after injury. ACE mRNA levels were quantified by polymerase chain reaction after reverse transcription. Measurement of ACE mRNA levels revealed a significant upregulation 2 and 8 days after injury, with no significant difference when compared with control tissue at later time points. ACE activity was also significantly enhanced at 2 and 8 days after injury, with no significant difference when compared with control tissue at later time points. In addition, the treatment with ramiprilat was more efficient in reducing neointima formation than that with HR 720. These data underlie the role of ACE in this model of restenosis. The early induction of ACE expression after endothelial injury but before significant changes in the vessel structure suggests that ACE activity might be one of the mechanisms that trigger neointima formation in the rat.


Key Words: angiotensin-converting enzyme inhibitors • angiotensin-converting enzyme • balloon injury • polymerase chain reaction




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. K. Dubey and E. K. Jackson
Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Tazawa, T. Nakane, and S. Chiba
Angiotensin II Type 1 Receptor Blockade Prevents Up-Regulation of Angiotensin II Type 1A Receptors in Rat Injured Artery
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 898 - 904.
[Abstract] [Full Text]